Decreased plasma cortisol in response to intramuscular ACTH in ocular hypertensives and primary open-angle glaucomas

Journal of Glaucoma

Volumn 16, Issue 3, 2007, Pages 282-286

  Schwartz, Bernard ^a,b,c   Rabin, Paul A ^b   Wysocki, Alice ^a   Martin, Jeff ^a  

^a Glaucoma Research Foundation   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

ACTH; Ocular hypertension; Open angle glaucoma; Plasma cortisol

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE;

ADRENAL SUPPRESSION; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; DRUG RESPONSE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTRAOCULAR HYPERTENSION; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; AGED; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; HYDROCORTISONE; INJECTIONS, INTRAMUSCULAR; MALE; OCULAR HYPERTENSION; SPECTROMETRY, FLUORESCENCE;

EID: 34247244248     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3180334ff6     Document Type: Article

References (27)

1. Khasanov N, Pomoshchnikov I. Glucocorticoid function of the adrenal cortex in glaucoma patients. Vestnik Oftal. 1971;2:34-38.
2. Schwartz B, Levene RZ. Plasma cortisol differences between normal and glaucomatous patients. Arch Ophthalmol. 1972;87:369-378.
3. Ray S, Mehra KS, Misra S, et al. Plasma cortisol in glaucoma. Ann Ophthalmol. 1977;9:1151-1154.
4. Schwartz B, Seddon JM. Increased plasma cortisol levels in ocular hypertension. Arch Ophthalmol. 1981;99:1791-1794.
5. Rozsival P, Hampl R, Obenberger J, et al. Aqueous humor and plasma cortisol levels in glaucoma and cataract patients. Curr Eye Res. 1981;7:391-396.
6. Schwartz B, McCarty G, Rosner B. Increased plasma free cortisol in ocular hypertension and open-angle glaucoma. Arch Ophthalmol. 1987;105:1060-1065.
7. Scheie HG. Width and pigmentation of the angle of the anterior chamber. A system of grading by gonioscopy. Arch Ophthalmol. 1950;58:510-512.
8. Schwartz B, Golden MA, Wiznia RA, et al. Differences of adrenal stress control mechanisms in glaucomas and normals-effect of vasopressin and pyrogen. Arch Ophthalmol. 1981;99:1770-1777.
9. Schwartz B, Wysocki A, Qi Y. Decreased response of plasma cortisol to intravenous metyrapone in ocular hypertension and primary open-angle glaucoma. J Glaucoma. 2005;14:474-481.
10. Schwartz B. Optic disc changes in ocular hypertension. Surv Ophthalmol. 1980;25:148-154.
11. Donaldson D, Prescott R, Kennedy S. Simultaneous stereoscopic fundus camera incorporating a single optic axis. Invest Ophthalmol Vis Sci. 1980;19:289-297.
12. Mattingly D. A simple fluorometric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Path. 1962;15:374-379.
13. Spencer-Peet J, Daly JR, Smith V. A simple method for improving the specificity of the fluorometric determination of adrenal corticosteroids in human plasma. J Endocrinol. 1965;31:235-244.
14. Siegel S, Castellan NJ Jr. Non-parametric Statistics for the Behavioral Sciences. 2nd ed. New York: McGraw-Hill; 1988.
15. Kleinbaum DG, Kupper LL. Applied Regression Analyses and Other Multivariate Methods. 3rd ed. North Scituate, MA: Duxbury Press; 1998.
16. Greig WR, Jasani MK, Boyle JA, et al. Corticotropin stimulation tests. In: James VHJ, Landon J, eds. Memoirs of the Society for Endocrinology, No. 17. The Investigation of Hypothalamic-Pituitary-Adrenal Function. Cambridge, UK: Cambridge University Press; 1968:175-192.
17. Knappe G. Adrenocortical stimulation tests with ACTH: developments and changes of a diagnostic procedure. Hormones. 1971;2:76-99.
18. Aron DC, Findling JW, Tyrrell JB. Glucocorticoids and adrenal androgens. In: Greenspan FS, Gardner DG, eds. Basic and Clinical Endocrinology. 6th ed. New York: Lange Medical Books/McGraw-Hill; 2001:334-376.
19. Nelson JK, Mackay JS, Sheridan B, et al. Intermittent therapy with corticotrophin. Lancet. 1966;2:78-82.
20. Schlaghecke R, Kornely E, Santen RT, et al. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. New Engl J Med. 1992;325:226-230.
21. Christy NP. Cushing's syndrome: the natural disease. In: Christy NP, ed. The Human Adrenal Cortex. New York: Harper and Row; 1971:359-394.
22. Staub JJ, Jenkins JS, Ratcliffe JG, et al. Comparison of corticotropin and corticosteroid response to lysine vasopressin, insulin and pyrogen in man. Br Med J. 1973;1:267-269.
23. Arnoldson H, Helander FE. The reaction of the pituitary-adrenocortical system to stress after prolonged corticosteroid therapy. Acta Med Scand. 1963;173:769-774.
24. Melby JC. Clinical pharmacology-systemic corticosteroids. Annu Rev Pharmacol Toxicol. 1977;17:511-527.
25. Carvalhaes-Neto N, Ramos L, Suchecki D, et al. The effect of hospitalization on the sleep pattern and on cortisol secretion of healthy elderly. Exp Aging Res. 2003;29:425-436.
26. Mason JW, Sachar ED, Fishman JR, et al. Corticosteroid responses to hospital admission. Arch Gen Psychiat. 1965;13:1-8.
27. Connolly CK, Gore MBR, Stanley N, et al. Single-dose dexamethasone suppression in normal subjects and hospital patients. Br Med J. 1968;2:665-667.